Miyake, K., Kawaguchi, K., Kiyuna, T., Miyake, M., Igarashi, K., Zhang, Z., . . . Hoffman, R. M. (2018). Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model. Cell Cycle.
Citación estilo ChicagoMiyake, Kentaro, et al. "Regorafenib Regresses an Imatinib-resistant Recurrent Gastrointestinal Stromal Tumor (GIST) With a Mutation in Exons 11 and 17 of C-kit in a Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model." Cell Cycle 2018.
Cita MLAMiyake, Kentaro, et al. "Regorafenib Regresses an Imatinib-resistant Recurrent Gastrointestinal Stromal Tumor (GIST) With a Mutation in Exons 11 and 17 of C-kit in a Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model." Cell Cycle 2018.